Thomas J. Polascik, MD, Duke University, Durham, North Carolina, discusses the role risk stratification tools play in focal therapy.
Interview produced by Prostatepedia
Keywords: focal therapy, risk stratification, genomic classifiers, multiparametric MRI, prostate cancer